Other News

Omron Healthcare Rolls Out Redesigned Line of Best-Selling Blood Pressure Monitors

LAKE FOREST, Ill., Oct. 17, 2019 /PRNewswire/ — Omron Healthcare, Inc., the number one doctor and pharmacist-recommended blood pressure brand, has rolled out newly redesigned models of its best-selling blood pressure monitors with new features. The redesigned upper arm and wrist blood pressure monitors build on the standard of quality Omron is […]

Orchestra BioMed™ Strengthens Management Team with Appointments of Expert Product Development Leaders Juan A. Lorenzo and Paul V. Goode, Ph.D.

NEW HOPE, Pa., Oct. 16, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced senior-level appointments to its product development teams. Juan Lorenzo, an expert in vascular devices, joins as vice […]

Neovasc Retains Westwicke, ICR for Integrated Communications Counsel

Company Ramps Up Commercialization of Neovasc Reducer™ and Development of Tiara™ Product Platforms, Primes for Pivotal Growth Period VANCOUVER, Oct. 16, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the […]

HeartBeam’s Breakthrough Technology to Bring Mobile Cardiovascular Diagnostic Services to Patients

MILL VALLEY, Calif., Oct. 16, 2019 /PRNewswire/ — Every year, nearly 800,000 Americans have a heart attack. Heart disease now accounts for one in four deaths, according to the Centers for Disease Control and Prevention. When patients have heart attack symptoms, the most important factor in a successful outcome is how quickly […]

Abbott Reports Third-Quarter 2019 Results

– Third-quarter sales growth of 5.5 percent; organic sales growth of 7.6 percent – Exceptional growth across key platforms of FreeStyle Libre, MitraClip and Alinity – Continues to strengthen portfolio with a steady cadence of new product approvals, reimbursement coverage and clinical data ABBOTT PARK, Ill., Oct. 16, 2019 /PRNewswire/ — Abbott […]

Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients

Stellarex’s unique coating enables a low therapeutic drug dose and has demonstrated a significant treatment effect and high safety profile Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio. The new 200mm […]

BioSig Opens a Technology Development Office in Rochester, MN

Westport, CT, Oct. 15, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company is opening […]

Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate

WINNIPEG, Oct. 15, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILETM-Heart Failure (SMILE-HF) Clinical Trial which was presented at the recent Heart Failure Society of America (“HFSA”) conference in Philadelphia, PA by Dr. William T. Abraham, the […]

Neovasc Announces Notice of US Patent Granted for Tiara™ Transcatheter Device for Treatment of Severe Mitral Regurgitation

VANCOUVER, Oct. 15, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the United States Patent […]

CHF Solutions Announces that James A. Haley Veterans’ Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow® System

First Study of Aquadex FlexFlow System Sponsored by United States Veterans Administration for Aquapheresis Treatment in Patients Suffering from Fluid Overload. First patient enrollment expected in the fourth quarter of 2019. EDEN PRAIRIE, Minn., Oct. 10, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), today announced that James A. Haley […]